{
    "clinical_study": {
        "@rank": "33345", 
        "arm_group": {
            "arm_group_label": "Drug", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to investigate the pharmacokinetics of serum iron (the amount\n      of iron in  blood) after single oral administration of 2 tablets of L0008 80 mg (as ferrous\n      sulphate) in women with iron deficiency anaemia."
        }, 
        "brief_title": "Ferrous Sulphate Supplement in Women With Iron Deficiency Anaemia", 
        "completion_date": {
            "#text": "March 2014", 
            "@type": "Actual"
        }, 
        "condition": "Iron Deficiency Anemia", 
        "condition_browse": {
            "mesh_term": [
                "Anemia", 
                "Deficiency Diseases", 
                "Anemia, Iron-Deficiency"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Women 18-45 years old with iron deficiency anaemia\n\n          -  haemoglobin level between 85 g/L and 105 g/L\n\n          -  serum ferritin level < 15 \u00b5g/L\n\n          -  D14 + 7 days of the menstruation cycle on the day of pharmacokinetic\n             evaluation\n\n          -  Standard diet\n\n        Exclusion Criteria:\n\n          -  - Anaemia related to other causes than iron deficiency and particularly  inflammatory\n             anaemia, anaemia due to marrow failure, haemopathy, haemoglobinopathies (sickle cell\n             disease, thalassemia), haemolytic anaemia, anaemia due to acute haemorrhage, or\n             anaemia related to chronic renal failure,\n\n          -  Haemochromatosis or iron overload of secondary origin (blood transfusion),\n\n          -  Long term treatment known to modify iron absorption,\n\n          -  Gastro duodenal ulcer,\n\n          -  Inflammatory bowel disease or any digestive disease which could modify iron\n             absorption,\n\n          -  Fructose intolerance, syndrome of malabsorption of glucose, galactose, deficit of\n             sucrase-isomaltase,\n\n          -  Serious or progressive disease (cardiac, pulmonary, hepatic, renal, haematological,\n             malignancy, autoimmune disease, infectious disease or neuropsychiatric disorders),\n\n          -  Surgery undergone within 1 month prior to selection visit or a surgery planned during\n             the study realization."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "45 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "55", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 20, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01757119", 
            "org_study_id": "L00008 CP 1 01", 
            "secondary_id": "2012-002190-63"
        }, 
        "intervention": {
            "arm_group_label": "Drug", 
            "description": "Oral administration (2 tablets)", 
            "intervention_name": "Tardyferon 80 mg", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 14, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Iasi", 
                        "country": "Romania"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Timisoara", 
                        "country": "Romania", 
                        "zip": "300244"
                    }
                }
            }
        ], 
        "location_countries": {
            "country": "Romania"
        }, 
        "number_of_arms": "1", 
        "official_title": "Study of the Pharmacokinetics of Serum Iron After Single Oral Administration of Ferrous Sulphate Supplement in Women With Iron Deficiency Anaemia", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "Romania: Ethics Committee", 
                "Romania: National Agency for Medicines and Medical Devices"
            ]
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Pharmacokinetic profile of serum iron after single oral administration of ferrous sulphate supplement by measuring Maximum Plasma concentration, Time of Maximum Concentration, Area under the iron plasma concentration curve.", 
            "measure": "Pharmacokinetic profile of serum iron after single oral administration of ferrous sulphate supplement", 
            "safety_issue": "No", 
            "time_frame": "Up to 24 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01757119"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Tolerability by evaluating the number of subjects with emergent adverse events", 
            "measure": "Tolerability of single administration  (reported adverse events)", 
            "safety_issue": "Yes", 
            "time_frame": "Up to 24 hours"
        }, 
        "source": "Pierre Fabre Medicament", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Pierre Fabre Medicament", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Endpoint Classification: Pharmacokinetics Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}